Tracey J. Collard
University Walk
Bristol, ENG, United Kingdom
Bristol, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Corrigendum to "BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination" [DNA Repair 115 (2022) 103331].
Journal: DNA repair
Published: December 10, 2024
Identifying targetable metabolic dependencies across colorectal cancer progression.
Journal: Molecular metabolism
Published: April 17, 2024
Gut bacteria promote proliferation in benign S/RG/C2 colorectal tumour cells, and promote proliferation, migration and invasion in malignant HCT116 cells.
Journal: Scientific reports
Published: March 15, 2023
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer.
Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer.
Journal: Exploration of targeted anti-tumor therapy
Published: January 19, 2023
Aspirin reprogrammes colorectal cancer cell metabolism and sensitises to glutaminase inhibition.
Journal: Cancer & metabolism
Published: November 21, 2022
BCL-3 loss sensitises colorectal cancer cells to DNA damage by targeting homologous recombination.
Journal: DNA repair
Published: November 26, 2021
5-Aminosalicylic acid inhibits stem cell function in human adenoma-derived cells: implications for chemoprophylaxis in colorectal tumorigenesis.
Journal: British journal of cancer
Published: May 12, 2020
BCL‑3 promotes cyclooxygenase‑2/prostaglandin E2 signalling in colorectal cancer.
Journal: International journal of oncology
Published: September 16, 2019
The role of B-Cell Lymphoma-3 (BCL-3) in enabling the hallmarks of cancer: implications for the treatment of colorectal carcinogenesis.
Journal: Carcinogenesis
Published: July 31, 2019
BCL-3 promotes a cancer stem cell phenotype by enhancing β-catenin signalling in colorectal tumour cells.
Journal: Disease models & mechanisms
Published: October 25, 2018
Cancer cell adaptation to hypoxia involves a HIF-GPRC5A-YAP axis.
Journal: EMBO molecular medicine
Published: August 26, 2018
Last Updated: 09/26/2026